Key result
In women with type 1 diabetes, being over 50 years of age (postmenopausal) was associated with a significantly increased prevalence of asymptomatic cardiovascular autonomic neuropathy (OR 3.3) compared to younger women.
Why the study?
Data regarding the interplay between sex and cardiovascular autonomic neuropathy in patients with type 1 diabetes are scarce and controversial.
Do sex differences and sex steroids influence the prevalence and severity of cardiovascular autonomic neuropathy in patients with type 1 diabetes?
Cross-Sectional (n=332)
No
Do sex differences and sex steroids influence the prevalence and severity of cardiovascular autonomic neuropathy in patients with type 1 diabetes?
Odds Ratio: 3.3 (95% CI 1.6–6.9)
Absolute Event Rate: 45.8% vs 20.4%
p-value: p=0.001
Menopause in women with type 1 diabetes is accompanied by a significant increase in the prevalence of asymptomatic cardiovascular autonomic neuropathy, with circulating androgens showing opposite associations with cardioautonomic function in men versus women.
May warrant closer monitoring for autonomic neuropathy post-menopause in type 1 diabetes; leaves open causal roles of sex steroids.
Background Sex differences characterize cardiovascular outcomes in patients with type 1 diabetes. Cardioautonomic neuropathy is a common complication of type 1 diabetes that associates increased morbi-mortality. Data regarding the interplay between sex and cardiovascular autonomic neuropathy are scarce and controversial in these patients. We aimed to address sex-related differences in the prevalence of seemingly asymptomatic cardioautonomic neuropathy in type 1 diabetes, and their associations with sex steroids. Methods We conducted a cross-sectional study including 322 consecutively recruited patients with type 1 diabetes. Cardioautonomic neuropathy was diagnosed using Ewing's score and power spectral heart rate data. We assessed sex hormones by liquid chromatography/tandem mass spectrometry. Results When considering all subjects as a whole, asymptomatic cardioautonomic neuropathy prevalence was not significantly different between women and men. When age was taken into account, the prevalence of cardioautonomic neuropathy was similar among young men and those > 50 years. However, in women > 50 years, the prevalence of cardioautonomic neuropathy doubled that of young women [45.8% (32.6; 59.7) vs. 20.4% (13.7; 29.2), respectively]. The OR of having cardioautonomic neuropathy was 3.3 higher in women > 50 years than in their younger counterparts. Furthermore, women presented more severe cardioautonomic neuropathy than men. These differences were even more marked when women were classified according their menopausal status instead of age. Peri- and menopausal women had an OR 3.5 (1.7; 7.2) of having CAN compared with their reproductive-aged counterparts [CAN prevalence: 51% (37; 65) vs. 23% (16; 32), respectively]. A binary logistic regression model (R 2 : 0.161; P = 0.001) displayed age > 50 years as a significant determinant of cardioautonomic neuropathy only in women. Androgens were positively associated with heart rate variability in men, and negatively in women. Accordingly, cardioautonomic neuropathy was associated with increased testosterone/estradiol ratio in women but to decreased testosterone concentrations in men. Conclusions Menopause in women with type 1 diabetes is accompanied by an increase in the prevalence of asymptomatic cardioautonomic neuropathy. This age-related excess risk of cardioautonomic neuropathy is not observed in men. Men and women with type 1 diabetes have opposite associations between circulating androgens and indexes of cardioautonomic function. Trial registration ClinicalTrials.gov Identifier: NCT04950634.
No takes yet. Share an insight, caveat, or question.
Nattero‐Chávez et al. (2023) conducted a cross-sectional in Type 1 diabetes (n=332). Age > 50 years (menopause) vs. Age ≤ 50 years was evaluated on Prevalence of asymptomatic cardioautonomic neuropathy (CAN) in women (OR 3.3, 95% CI 1.6-6.9, p=0.001). In women with type 1 diabetes, being over 50 years of age (postmenopausal) was associated with a significantly increased prevalence of asymptomatic cardiovascular autonomic neuropathy (OR 3.3) compared to younger women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: